Abstract / Summary
This record details the architecture and operational capabilities of a fully developed, AI-assisted neurocognitive assessment software. Engineered for the precise screening and monitoring of neurodegenerative conditions—specifically Parkinson's Disease (PD), Essential Tremor (ET), and Dementia—the platform is fully finalized and currently in active clinical use. The software successfully integrates high-polling rate hardware with proprietary computational filtering pipelines, effectively eliminating hardware-induced latency and jitter. This operational framework guarantees sub-millisecond accuracy for the extraction and analysis of digital biomarkers in real-world clinical settings. As a fully functional end-to-end digital infrastructure, it provides neurologists and clinicians with real-time, actionable data for movement disorder diagnostics and cognitive evaluations.